| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |